(CAS 89304-26-7)
For active pharmaceutical ingredients (APIs) related to Oxalomalic Acid (sodium salt), see Cayman Pharma
![]() |
![]() |
![]() |
![]() |
|
Aconitase catalyzes the stereospecific isomerization of citrate to isocitrate in the first step of the citric acid cycle. It acts as an iron regulatory protein (IRP), controlling the translation of proteins involved in iron metabolism when iron is scarce and resumes aconitase activity when iron is abundant. Aconitase is now recognized as a regulator of iron- |
|
1
Gerber, D.E. EGFR inhibition in the treatment of non-
2
Ruffo, A., Testa, E., Adinolfi, A., et al. Control of the citric acid cycle by glyoxylate. Mechanism of the inhibition by oxalomalate and γ-
3
Festa, M., Colonna, A., Pietropaolo, C., et al. Oxalomalate, a competitive inhibitor of aconitase, modulates the RNA-
4
McGahan, M.C., Harned, J., Mukunnemkeril, M., et al. Iron alters glutamate secretion by regulating cytosolic aconitase activity. Am J Physiol Cell Physiol 288 1117-
|
![]() | Download Product Insert 128 Kb PDF |
Prices listed here are the Manufacturer's Suggested European Retail Price. The actual prices quoted by each individual distributor may vary. Please visit the Global Buyer's Guide on the Cayman Chemical (world) website to locate a distributor in your region.
This product is also available to buy in bulk quantities. Please contact us for a quote or to purchase.
Cayman strives to be a reliable biochemical reagent vendor by providing the best possible products and services. To ask for assistance with one of our products please contact our Technical Help staff.
Warning This product is not for human or veterinary use.
|
Item total €0.00
Shopping cart total €0.00 |